Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Payables (2018 - 2025)

AVITA Medical (RCEL) has disclosed Payables for 4 consecutive years, with $9.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Payables rose 42.34% year-over-year to $9.0 million, compared with a TTM value of $9.0 million through Dec 2025, up 42.34%, and an annual FY2025 reading of $9.0 million, up 42.34% over the prior year.
  • Payables was $9.0 million for Q4 2025 at AVITA Medical, up from $8.1 million in the prior quarter.
  • Across five years, Payables topped out at $9.0 million in Q4 2025 and bottomed at $2.4 million in Q1 2022.
  • Average Payables over 4 years is $4.8 million, with a median of $4.0 million recorded in 2023.
  • The sharpest move saw Payables decreased 3.18% in 2023, then skyrocketed 93.81% in 2025.
  • Year by year, Payables stood at $3.0 million in 2022, then rose by 26.35% to $3.8 million in 2023, then skyrocketed by 65.94% to $6.3 million in 2024, then surged by 42.34% to $9.0 million in 2025.
  • Business Quant data shows Payables for RCEL at $9.0 million in Q4 2025, $8.1 million in Q3 2025, and $7.3 million in Q2 2025.